Press Releases

Press Releases

February 5, 2025

NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization

January 21, 2025

NurExone Secures C$1.2 Million through Warrant Exercises and Completion of Private Placement and Appoints New R&D Director

December 6, 2024

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

November 27, 2024

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

November 13, 2024

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

November 1, 2024

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

October 23, 2024

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

September 26, 2024

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

September 12, 2024

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

Set layout popup